Novanta (NASDAQ:NOVT) Announces Quarterly Earnings Results

Novanta (NASDAQ:NOVT) released its quarterly earnings data on Wednesday. The technology company reported $0.89 EPS for the quarter, topping the consensus estimate of $0.83 by $0.06, FiscalAI reports. The company had revenue of $265.81 million for the quarter, compared to the consensus estimate of $262.30 million. Novanta had a return on equity of 12.06% and a net margin of 5.35%.Novanta’s quarterly revenue was up 10.3% on a year-over-year basis. During the same period last year, the business posted $0.76 EPS. Novanta updated its FY 2026 guidance to 3.680-3.740 EPS and its Q3 2026 guidance to 0.950-1.000 EPS.

Novanta Stock Down 4.0%

Shares of NASDAQ:NOVT traded down $6.37 on Wednesday, reaching $153.12. The company had a trading volume of 548,040 shares, compared to its average volume of 429,064. Novanta has a 52-week low of $98.27 and a 52-week high of $171.85. The firm’s 50 day simple moving average is $153.85 and its 200-day simple moving average is $141.21. The firm has a market capitalization of $5.78 billion, a PE ratio of 47.61 and a beta of 1.68. The company has a current ratio of 3.56, a quick ratio of 2.69 and a debt-to-equity ratio of 0.15.

Insider Buying and Selling at Novanta

In related news, CEO Matthijs Glastra sold 6,500 shares of the company’s stock in a transaction on Thursday, July 2nd. The stock was sold at an average price of $161.13, for a total transaction of $1,047,345.00. Following the completion of the sale, the chief executive officer directly owned 29,761 shares in the company, valued at $4,795,389.93. This represents a 17.93% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 1.20% of the stock is owned by company insiders.

Hedge Funds Weigh In On Novanta

A number of large investors have recently added to or reduced their stakes in the company. Corient Private Wealth LLC purchased a new position in shares of Novanta in the 4th quarter worth approximately $275,000. Invesco Ltd. lifted its position in Novanta by 9.0% during the fourth quarter. Invesco Ltd. now owns 68,089 shares of the technology company’s stock valued at $8,102,000 after acquiring an additional 5,600 shares during the last quarter. Alberta Investment Management Corp purchased a new stake in Novanta during the fourth quarter valued at approximately $1,285,000. Mercer Global Advisors Inc. ADV acquired a new stake in Novanta in the fourth quarter valued at approximately $314,000. Finally, Empowered Funds LLC boosted its stake in Novanta by 16.7% in the fourth quarter. Empowered Funds LLC now owns 7,888 shares of the technology company’s stock valued at $939,000 after acquiring an additional 1,128 shares in the last quarter. 98.35% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

A number of equities analysts have recently issued reports on the company. Wall Street Zen downgraded Novanta from a “buy” rating to a “hold” rating in a research report on Saturday. Robert W. Baird set a $180.00 price objective on shares of Novanta in a research note on Tuesday, June 9th. Finally, Weiss Ratings reiterated a “hold (c-)” rating on shares of Novanta in a report on Wednesday, July 15th. One research analyst has rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Hold” and an average target price of $180.00.

Novanta Company Profile

Novanta, Inc (NASDAQ: NOVT) is a global technology company that designs and manufactures precision components, subsystems and software used in advanced photonics and motion control applications. The company serves customers in the medical device and advanced industrial markets, supplying critical technologies for diagnostics and therapeutic systems, semiconductor and electronics manufacturing, and scientific instrumentation. Novanta’s product portfolio includes laser control modules, optics, beam delivery systems, high-precision motors, actuators, stages, and fluidics solutions designed to meet stringent accuracy and reliability requirements.

Novanta’s Photonics segment delivers laser and energy delivery components that enable minimally invasive surgical procedures and diagnostic imaging.